Latest "SPM" News Stories

17:15 EDT 24th April 2018 | BioPortfolio

Here are the most relevant search results for "SPM" found in our extensive news archives from over 250 global news sources.

More Information about SPM on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SPM for you to read. Along with our medical data and news we also list SPM Clinical Trials, which are updated daily. BioPortfolio also has a large database of SPM Companies for you to search.

Showing News Articles 1–25 of 440,000+

Tuesday 24th April 2018

Herbalife Ltd. Announces Strategic Name Change to Herbalife Nutrition Ltd., Reflecting its Leadership as a Premier Global Nutrition Company

Shareholders Approve Two-for-One Stock Split Herbalife Ltd. (NYSE: HLF) today announced its name change to “Herbalife Nutrition Ltd.”, as approved by shareholders at its annual general meeting of shareholders. The evolution of the Company’s name reflects the investments Herbalife Nutrition has made to become a leader in the nutrition industry, an...

20152023 World Polyisobutylene PIB CAS 9003274 Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Cerenis Therapeutics Holding SA CEREN Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryCerenis Therapeutics Holding SA Cerenis is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company is developing a portfolio of HDL therapies for the rapid regression of atherosclerotic plaque in highrisk patients such as patients with HDL deficiency, and postACS patients. It is also developing drugs that ...

Celebrating Its 16th Year, the Donate Life Run/Walk and Family Festival Continues Its Mission to Promote the Importance of Organ, Eye and Tissue Donation in Southern California

Grammy Award-Winning Music Group All-4-One, Phillip Palmer, City Officials and Thousands More Who Have Been Touched by Donation Will Gather at Cal State Fullerton to Culminate Donate Life Month Celebrations With a continuous goal of inspiring and educating the community about the importance of organ, eye and tissue donation in Southern California, ...

Pharmaceutical Packaging Equipment Procurement Research – Market Trends and Spend Analysis by SpendEdge

SpendEdge, a global procurement intelligence advisory firm, has announced the release of their ‘

American Renal Associates Holdings, Inc. Announces First Quarter 2018 Earnings Release Date and Conference Call

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of dialysis services, announced today that it will release its first quarter 2018 financial results after the market close on Tuesday, May 8, 2018, to be followed by a conference call on Wednesday, May 9, 2018 at 9:00 a.m. (Eastern Time). The conference call can be accessed l...

Daehan New Pharm Co Ltd 054670 Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryDaehan New Pharm Co Ltd Daehan New Pharm is a pharmaceutical company that manufactures nutritional supplements and drugs. The company develops and distributes generic and ethical pharmaceuticals, herbals and health supplements and veterinary drugs. It offers pharmaceuticals, animal health and nutrition, bioprocess, health supplements and medical devices. Daehan New Pharm's products comprise...

Ocrelizumab Demonstrates Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis

NewsFour years of continuous treatment with Ocrelizumab showed a sustained reduction in underlying disease activity in relapsing MS (RMS) in analysis from the open-label extension period.

Department of Culture and Tourism - Abu Dhabi Commemorates Late Sheikh Zayed at Zayed International Charity Marathon in New York

The Department of Culture and Tourism - Abu Dhabi (DCT Abu Dhabi) is organizing cultural and heritage activities as part of the 14th Zayed International Charity Marathon, ‘UAE Healthy Kidney 10K’, to be held at Central Park in New York on April 29, 2018. The marathon is held in memory of the late Sheikh Zayed bin Sultan Al Nahyan, the founding...

USANA Health Sciences Reports Record First Quarter 2018 Net Sales and Increases 2018 Outlook

Record first quarter net sales of $292.0 million, an increase of 14.4% year-over-year First quarter diluted earnings per share increased 38.4% to $1.19 per share USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 31, 2018. Financial Perfo...

Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2018 financial results on Tuesday, May 8, 2018, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail. The conference call is being webcast...

Surgery Recovery Program Slashes Opioid Use, Benefits Patients, Cuts Costs

NewsA special recovery program for thoracic surgery patients developed and implemented at the University of Virginia Health System is getting patients home sooner while decreasing both healthcare costs and opioid use, a review of the first year of the program shows.

Hurvitz Shares Insight on Breaking the Barrier With Biosimilars

Sara A. Hurvitz, MD, discusses the development of biosimilars and their potential use in the breast cancer field.

Agilent Announces Executive Appointments

Jacob Thaysen named President, Life Sciences and Applied Markets Group, moving from Agilent’s Diagnostics and Genomics Group Sam Raha appointed President, Diagnostics and Genomics Group, moving from Agilent Strategy and Corporate Development Agilent Technologies Inc. (NYSE: A) today announced that Jacob Thaysen, cur...

Jamieson Wellness Inc. Announces Date of First Quarter 2018 Financial Results and Conference Call

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its first quarter 2018 financial results after the market close on Wednesday, May 9, 2018. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the first quarter 2018 results. The call can be ...

Revance Therapeutics to Release First Quarter 2018 Financial Results on Tuesday, May 8, 2018

-Conference Call Scheduled for Tuesday, May 8, 2018 at 4:30pm ET- Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will release first quarter 2018 financial results on Tuesday, May 8, 2018 after the close of market. Rev...

Illumina Reports Financial Results for First Quarter of Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2018. First quarter 2018 results: Revenue of $782 million, a 31% increase compared to $598 million in the first quarter of 2017 GAAP net income attributable to Illumina stockholders for the quarter of...

Five Prime Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on May 8

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, will report its first quarter 2018 financial results on Tuesday, May 8, 2018, after the U.S. financial markets close. Five Prime will host a conference call and liv

Anika to Present at the 2018 Deutsche Bank Health Care Conference on May 8, 2018

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced that its President and Chief Ex

Jeunesse® Global Honored among Best Places to Work in Direct Selling for Second Time

For a second time, Jeunesse was named as one of the Best Places to Work in Direct Selling by “Direct Selling News.” Jeunesse is one of just 13 companies to be honored in the 2018 competition. This press release features multimedia. View the full release here: Global direct selling co

Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 8, 2018, at 4:30 p.m. EDT to discuss its financial results for the fiscal 2018 second quarter ended March 31, 2018. Conference Call and Webcast Details Investors may access a live audio webcast on the Company's website at h...

Lori Henderson Joins Moderna as General Counsel and Corporate Secretary

Moderna Therapeutics, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Lori Henderson has joined the company as General Counsel. She will serve on Moderna’s Executive Committee and as Corporate Secretary, reporting to ...

China Biologic to Report First Quarter of 2018 Financial Results

- Provides Preliminary First Quarter 2018 Results and Earnings Announcement Date - BEIJING, April 24, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company will release first quarter 2018 financial results o...

STAT Plus: Public speakers at FDA advisory meetings have financial conflicts, but do they sway outcomes?

About one-fifth of the conflicted speakers did not disclose financial ties to drug companies.

University of Oxford Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryUniversity of Oxford UO is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and continuity education departments. Its mathematical, physical and life sciences courses comprise doctoral tra...

Quick Search


News Quicklinks